Published in Healthcare Finance, Tax and Law Weekly, November 19th, 2008
In a letter presented to Mr. Geller on November 4, 2008, several reasons for Sellers' dissatisfaction were cited. Among them was Geller's excessive compensation in light of the company's declining market cap and the dismal track record of Board oversight with respect to reigning in management. In fiscal year 2008,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.